IDPN and IPN therapies are a go-to for effectively helping increasing dialysis patient’s albumin and prealbumin levels when oral intake alone proves inadequate. Other benefits can include increasing BMI and patient appetite, preventing weight loss; decreasing inflammation, fluid retention, malnutrition and hospitalizations.
⠀⠀⠀⠀⠀⠀⠀⠀⠀
Criteria for initiating therapy include any of the below:
👉🏼 Continued decline of albumin < 3.5 g/dL
or
👉🏼 BMI <20
or
👉🏼 Continued weight loss ≥5%
If you or your patient want more information on Intradialytic Parenteral Nutrition or Intraperitoneal Nutrition, please contact us at 866-348-0441 or email us at info@pcacorp.com
Did you miss our last webinar? You're still in time! Learn more on how to evaluate standard counseling approaches to reduce fluid overload in dialysis patients.
